https://doi.org/10.1038/ncomms10872
D
Defang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
5.6K
Citations
41
h-index
108
i10-index
Defang Li is an academic researcher from Hong Kong Baptist University. The author has contributed to research in topics: Pharmacological Effects of Natural Compounds & MicroRNA in disease regulation & Bone Metabolism and Diseases. The author has an h-index of 41, co-authored 173 publications.
ORCID: 0000-0003-4151-9151Papers by this author
worksOsteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
2016 · Nature Communications · 579 citations
Progress of research into the pharmacological effect and clinical application of the traditional Chinese medicine Rehmanniae Radix
2023 · Biomedicine & Pharmacotherapy · 75 citations
https://doi.org/10.1016/j.biopha.2023.115809
Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells
2019 · Biomedicine & Pharmacotherapy · 63 citations
https://doi.org/10.1016/j.biopha.2019.109763
Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis
2016 · Scientific Reports · 48 citations
https://doi.org/10.1038/srep36114
Bone-derived exosomes
2017 · Current Opinion in Pharmacology · 44 citations
https://doi.org/10.1016/j.coph.2017.08.008
Comparison of the methods for generating single-stranded DNA in SELEX
2015 · The Analyst · 30 citations
https://doi.org/10.1039/c5an00244c
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat